TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Anal and Colorectal Cancer Market Insights, Forecast to 2028

Global Anal and Colorectal Cancer Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 21 July 2022
  • Pages :116
  • Formats:
  • Report Code:SMR-7222309
OfferClick for best price

Best Price: $3920

Anal Colorectal Cancer Market Size, Share 2022


Market Analysis and Insights: Global Anal Colorectal Cancer Market

The global Anal Colorectal Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anal Colorectal Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anal Colorectal Cancer market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anal Colorectal Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anal Colorectal Cancer market.

Global Anal Colorectal Cancer Scope and Market Size

Anal and Colorectal Cancer market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Anal and Colorectal Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Surgery

Radiation therapy

Colorectal cancer chemotherapy

Targeted therapy

Immunotherapy

Segment by Application

Hospitals

Ambulatory surgery centers

Cancer research centers

By Company

Abbott Diagnostics

Advaxis

Abbott

Amgen

Atara Biotherapeutics

Bayer

Metabiomics

Beckman Coulter

BeiGene

Boehringer Ingelheim

Clinical Genomics

EDP Biotech

Eli Lilly

Epigenomics

Exact Sciences

Genomictree

Immunovaccine

ISA Pharmaceuticals

Merck

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Anal Colorectal Cancer product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Anal Colorectal Cancer, with price, sales, revenue, and global market share of Anal Colorectal Cancer from 2019 to 2022.

Chapter 3, the Anal Colorectal Cancer competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Anal Colorectal Cancer breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Anal Colorectal Cancer market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Anal Colorectal Cancer.

Chapter 13, 14, and 15, to describe Anal Colorectal Cancer sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Anal Colorectal Cancer Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Anal and Colorectal Cancer Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 116 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anal and Colorectal Cancer Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Surgery
1.2.3 Radiation therapy
1.2.4 Colorectal cancer chemotherapy
1.2.5 Targeted therapy
1.2.6 Immunotherapy
1.3 Market by Application
1.3.1 Global Anal and Colorectal Cancer Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory surgery centers
1.3.4 Cancer research centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anal and Colorectal Cancer Market Perspective (2017-2028)
2.2 Anal and Colorectal Cancer Growth Trends by Region
2.2.1 Anal and Colorectal Cancer Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anal and Colorectal Cancer Historic Market Size by Region (2017-2022)
2.2.3 Anal and Colorectal Cancer Forecasted Market Size by Region (2023-2028)
2.3 Anal and Colorectal Cancer Market Dynamics
2.3.1 Anal and Colorectal Cancer Industry Trends
2.3.2 Anal and Colorectal Cancer Market Drivers
2.3.3 Anal and Colorectal Cancer Market Challenges
2.3.4 Anal and Colorectal Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anal and Colorectal Cancer Players by Revenue
3.1.1 Global Top Anal and Colorectal Cancer Players by Revenue (2017-2022)
3.1.2 Global Anal and Colorectal Cancer Revenue Market Share by Players (2017-2022)
3.2 Global Anal and Colorectal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anal and Colorectal Cancer Revenue
3.4 Global Anal and Colorectal Cancer Market Concentration Ratio
3.4.1 Global Anal and Colorectal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anal and Colorectal Cancer Revenue in 2021
3.5 Anal and Colorectal Cancer Key Players Head office and Area Served
3.6 Key Players Anal and Colorectal Cancer Product Solution and Service
3.7 Date of Enter into Anal and Colorectal Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anal and Colorectal Cancer Breakdown Data by Type
4.1 Global Anal and Colorectal Cancer Historic Market Size by Type (2017-2022)
4.2 Global Anal and Colorectal Cancer Forecasted Market Size by Type (2023-2028)
5 Anal and Colorectal Cancer Breakdown Data by Application
5.1 Global Anal and Colorectal Cancer Historic Market Size by Application (2017-2022)
5.2 Global Anal and Colorectal Cancer Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anal and Colorectal Cancer Market Size (2017-2028)
6.2 North America Anal and Colorectal Cancer Market Size by Type
6.2.1 North America Anal and Colorectal Cancer Market Size by Type (2017-2022)
6.2.2 North America Anal and Colorectal Cancer Market Size by Type (2023-2028)
6.2.3 North America Anal and Colorectal Cancer Market Share by Type (2017-2028)
6.3 North America Anal and Colorectal Cancer Market Size by Application
6.3.1 North America Anal and Colorectal Cancer Market Size by Application (2017-2022)
6.3.2 North America Anal and Colorectal Cancer Market Size by Application (2023-2028)
6.3.3 North America Anal and Colorectal Cancer Market Share by Application (2017-2028)
6.4 North America Anal and Colorectal Cancer Market Size by Country
6.4.1 North America Anal and Colorectal Cancer Market Size by Country (2017-2022)
6.4.2 North America Anal and Colorectal Cancer Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Anal and Colorectal Cancer Market Size (2017-2028)
7.2 Europe Anal and Colorectal Cancer Market Size by Type
7.2.1 Europe Anal and Colorectal Cancer Market Size by Type (2017-2022)
7.2.2 Europe Anal and Colorectal Cancer Market Size by Type (2023-2028)
7.2.3 Europe Anal and Colorectal Cancer Market Share by Type (2017-2028)
7.3 Europe Anal and Colorectal Cancer Market Size by Application
7.3.1 Europe Anal and Colorectal Cancer Market Size by Application (2017-2022)
7.3.2 Europe Anal and Colorectal Cancer Market Size by Application (2023-2028)
7.3.3 Europe Anal and Colorectal Cancer Market Share by Application (2017-2028)
7.4 Europe Anal and Colorectal Cancer Market Size by Country
7.4.1 Europe Anal and Colorectal Cancer Market Size by Country (2017-2022)
7.4.2 Europe Anal and Colorectal Cancer Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anal and Colorectal Cancer Market Size (2017-2028)
8.2 Asia-Pacific Anal and Colorectal Cancer Market Size by Type
8.2.1 Asia-Pacific Anal and Colorectal Cancer Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Anal and Colorectal Cancer Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Anal and Colorectal Cancer Market Share by Type (2017-2028)
8.3 Asia-Pacific Anal and Colorectal Cancer Market Size by Application
8.3.1 Asia-Pacific Anal and Colorectal Cancer Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Anal and Colorectal Cancer Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Anal and Colorectal Cancer Market Share by Application (2017-2028)
8.4 Asia-Pacific Anal and Colorectal Cancer Market Size by Region
8.4.1 Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anal and Colorectal Cancer Market Size (2017-2028)
9.2 Latin America Anal and Colorectal Cancer Market Size by Type
9.2.1 Latin America Anal and Colorectal Cancer Market Size by Type (2017-2022)
9.2.2 Latin America Anal and Colorectal Cancer Market Size by Type (2023-2028)
9.2.3 Latin America Anal and Colorectal Cancer Market Share by Type (2017-2028)
9.3 Latin America Anal and Colorectal Cancer Market Size by Application
9.3.1 Latin America Anal and Colorectal Cancer Market Size by Application (2017-2022)
9.3.2 Latin America Anal and Colorectal Cancer Market Size by Application (2023-2028)
9.3.3 Latin America Anal and Colorectal Cancer Market Share by Application (2017-2028)
9.4 Latin America Anal and Colorectal Cancer Market Size by Country
9.4.1 Latin America Anal and Colorectal Cancer Market Size by Country (2017-2022)
9.4.2 Latin America Anal and Colorectal Cancer Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anal and Colorectal Cancer Market Size (2017-2028)
10.2 Middle East & Africa Anal and Colorectal Cancer Market Size by Type
10.2.1 Middle East & Africa Anal and Colorectal Cancer Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Anal and Colorectal Cancer Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Anal and Colorectal Cancer Market Share by Type (2017-2028)
10.3 Middle East & Africa Anal and Colorectal Cancer Market Size by Application
10.3.1 Middle East & Africa Anal and Colorectal Cancer Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Anal and Colorectal Cancer Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Anal and Colorectal Cancer Market Share by Application (2017-2028)
10.4 Middle East & Africa Anal and Colorectal Cancer Market Size by Country
10.4.1 Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Anal and Colorectal Cancer Introduction
11.1.4 Abbott Diagnostics Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.1.5 Abbott Diagnostics Recent Developments
11.2 Advaxis
11.2.1 Advaxis Company Details
11.2.2 Advaxis Business Overview
11.2.3 Advaxis Anal and Colorectal Cancer Introduction
11.2.4 Advaxis Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.2.5 Advaxis Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Anal and Colorectal Cancer Introduction
11.3.4 Abbott Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.3.5 Abbott Recent Developments
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Anal and Colorectal Cancer Introduction
11.4.4 Amgen Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.4.5 Amgen Recent Developments
11.5 Atara Biotherapeutics
11.5.1 Atara Biotherapeutics Company Details
11.5.2 Atara Biotherapeutics Business Overview
11.5.3 Atara Biotherapeutics Anal and Colorectal Cancer Introduction
11.5.4 Atara Biotherapeutics Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.5.5 Atara Biotherapeutics Recent Developments
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Anal and Colorectal Cancer Introduction
11.6.4 Bayer Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.6.5 Bayer Recent Developments
11.7 Metabiomics
11.7.1 Metabiomics Company Details
11.7.2 Metabiomics Business Overview
11.7.3 Metabiomics Anal and Colorectal Cancer Introduction
11.7.4 Metabiomics Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.7.5 Metabiomics Recent Developments
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Details
11.8.2 Beckman Coulter Business Overview
11.8.3 Beckman Coulter Anal and Colorectal Cancer Introduction
11.8.4 Beckman Coulter Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.8.5 Beckman Coulter Recent Developments
11.9 BeiGene
11.9.1 BeiGene Company Details
11.9.2 BeiGene Business Overview
11.9.3 BeiGene Anal and Colorectal Cancer Introduction
11.9.4 BeiGene Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.9.5 BeiGene Recent Developments
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Company Details
11.10.2 Boehringer Ingelheim Business Overview
11.10.3 Boehringer Ingelheim Anal and Colorectal Cancer Introduction
11.10.4 Boehringer Ingelheim Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.10.5 Boehringer Ingelheim Recent Developments
11.11 Clinical Genomics
11.11.1 Clinical Genomics Company Details
11.11.2 Clinical Genomics Business Overview
11.11.3 Clinical Genomics Anal and Colorectal Cancer Introduction
11.11.4 Clinical Genomics Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.11.5 Clinical Genomics Recent Developments
11.12 EDP Biotech
11.12.1 EDP Biotech Company Details
11.12.2 EDP Biotech Business Overview
11.12.3 EDP Biotech Anal and Colorectal Cancer Introduction
11.12.4 EDP Biotech Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.12.5 EDP Biotech Recent Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Anal and Colorectal Cancer Introduction
11.13.4 Eli Lilly Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.13.5 Eli Lilly Recent Developments
11.14 Epigenomics
11.14.1 Epigenomics Company Details
11.14.2 Epigenomics Business Overview
11.14.3 Epigenomics Anal and Colorectal Cancer Introduction
11.14.4 Epigenomics Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.14.5 Epigenomics Recent Developments
11.15 Exact Sciences
11.15.1 Exact Sciences Company Details
11.15.2 Exact Sciences Business Overview
11.15.3 Exact Sciences Anal and Colorectal Cancer Introduction
11.15.4 Exact Sciences Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.15.5 Exact Sciences Recent Developments
11.16 Genomictree
11.16.1 Genomictree Company Details
11.16.2 Genomictree Business Overview
11.16.3 Genomictree Anal and Colorectal Cancer Introduction
11.16.4 Genomictree Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.16.5 Genomictree Recent Developments
11.17 Immunovaccine
11.17.1 Immunovaccine Company Details
11.17.2 Immunovaccine Business Overview
11.17.3 Immunovaccine Anal and Colorectal Cancer Introduction
11.17.4 Immunovaccine Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.17.5 Immunovaccine Recent Developments
11.18 ISA Pharmaceuticals
11.18.1 ISA Pharmaceuticals Company Details
11.18.2 ISA Pharmaceuticals Business Overview
11.18.3 ISA Pharmaceuticals Anal and Colorectal Cancer Introduction
11.18.4 ISA Pharmaceuticals Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.18.5 ISA Pharmaceuticals Recent Developments
11.19 Merck
11.19.1 Merck Company Details
11.19.2 Merck Business Overview
11.19.3 Merck Anal and Colorectal Cancer Introduction
11.19.4 Merck Revenue in Anal and Colorectal Cancer Business (2017-2022)
11.19.5 Merck Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Anal and Colorectal Cancer Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Surgery
Table 3. Key Players of Radiation therapy
Table 4. Key Players of Colorectal cancer chemotherapy
Table 5. Key Players of Targeted therapy
Table 6. Key Players of Immunotherapy
Table 7. Global Anal and Colorectal Cancer Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Anal and Colorectal Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Anal and Colorectal Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Anal and Colorectal Cancer Market Share by Region (2017-2022)
Table 11. Global Anal and Colorectal Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Anal and Colorectal Cancer Market Share by Region (2023-2028)
Table 13. Anal and Colorectal Cancer Market Trends
Table 14. Anal and Colorectal Cancer Market Drivers
Table 15. Anal and Colorectal Cancer Market Challenges
Table 16. Anal and Colorectal Cancer Market Restraints
Table 17. Global Anal and Colorectal Cancer Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Anal and Colorectal Cancer Revenue Share by Players (2017-2022)
Table 19. Global Top Anal and Colorectal Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anal and Colorectal Cancer as of 2021)
Table 20. Ranking of Global Top Anal and Colorectal Cancer Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Anal and Colorectal Cancer Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Anal and Colorectal Cancer Product Solution and Service
Table 24. Date of Enter into Anal and Colorectal Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anal and Colorectal Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Anal and Colorectal Cancer Revenue Market Share by Type (2017-2022)
Table 28. Global Anal and Colorectal Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Anal and Colorectal Cancer Revenue Market Share by Type (2023-2028)
Table 30. Global Anal and Colorectal Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Anal and Colorectal Cancer Revenue Share by Application (2017-2022)
Table 32. Global Anal and Colorectal Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Anal and Colorectal Cancer Revenue Share by Application (2023-2028)
Table 34. North America Anal and Colorectal Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Anal and Colorectal Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Anal and Colorectal Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Anal and Colorectal Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Anal and Colorectal Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Anal and Colorectal Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Anal and Colorectal Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Anal and Colorectal Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Anal and Colorectal Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Anal and Colorectal Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Anal and Colorectal Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Anal and Colorectal Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Anal and Colorectal Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Anal and Colorectal Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Anal and Colorectal Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Anal and Colorectal Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Anal and Colorectal Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Anal and Colorectal Cancer Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Anal and Colorectal Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Anal and Colorectal Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Anal and Colorectal Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Anal and Colorectal Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Anal and Colorectal Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Anal and Colorectal Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Anal and Colorectal Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Anal and Colorectal Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Anal and Colorectal Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Anal and Colorectal Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Anal and Colorectal Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Anal and Colorectal Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 64. Abbott Diagnostics Company Details
Table 65. Abbott Diagnostics Business Overview
Table 66. Abbott Diagnostics Anal and Colorectal Cancer Product
Table 67. Abbott Diagnostics Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 68. Abbott Diagnostics Recent Developments
Table 69. Advaxis Company Details
Table 70. Advaxis Business Overview
Table 71. Advaxis Anal and Colorectal Cancer Product
Table 72. Advaxis Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 73. Advaxis Recent Developments
Table 74. Abbott Company Details
Table 75. Abbott Business Overview
Table 76. Abbott Anal and Colorectal Cancer Product
Table 77. Abbott Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 78. Abbott Recent Developments
Table 79. Amgen Company Details
Table 80. Amgen Business Overview
Table 81. Amgen Anal and Colorectal Cancer Product
Table 82. Amgen Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 83. Amgen Recent Developments
Table 84. Atara Biotherapeutics Company Details
Table 85. Atara Biotherapeutics Business Overview
Table 86. Atara Biotherapeutics Anal and Colorectal Cancer Product
Table 87. Atara Biotherapeutics Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 88. Atara Biotherapeutics Recent Developments
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Anal and Colorectal Cancer Product
Table 92. Bayer Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 93. Bayer Recent Developments
Table 94. Metabiomics Company Details
Table 95. Metabiomics Business Overview
Table 96. Metabiomics Anal and Colorectal Cancer Product
Table 97. Metabiomics Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 98. Metabiomics Recent Developments
Table 99. Beckman Coulter Company Details
Table 100. Beckman Coulter Business Overview
Table 101. Beckman Coulter Anal and Colorectal Cancer Product
Table 102. Beckman Coulter Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 103. Beckman Coulter Recent Developments
Table 104. BeiGene Company Details
Table 105. BeiGene Business Overview
Table 106. BeiGene Anal and Colorectal Cancer Product
Table 107. BeiGene Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 108. BeiGene Recent Developments
Table 109. Boehringer Ingelheim Company Details
Table 110. Boehringer Ingelheim Business Overview
Table 111. Boehringer Ingelheim Anal and Colorectal Cancer Product
Table 112. Boehringer Ingelheim Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 113. Boehringer Ingelheim Recent Developments
Table 114. Clinical Genomics Company Details
Table 115. Clinical Genomics Business Overview
Table 116. Clinical Genomics Anal and Colorectal Cancer Product
Table 117. Clinical Genomics Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 118. Clinical Genomics Recent Developments
Table 119. EDP Biotech Company Details
Table 120. EDP Biotech Business Overview
Table 121. EDP Biotech Anal and Colorectal Cancer Product
Table 122. EDP Biotech Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 123. EDP Biotech Recent Developments
Table 124. Eli Lilly Company Details
Table 125. Eli Lilly Business Overview
Table 126. Eli Lilly Anal and Colorectal Cancer Product
Table 127. Eli Lilly Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 128. Eli Lilly Recent Developments
Table 129. Epigenomics Company Details
Table 130. Epigenomics Business Overview
Table 131. Epigenomics Anal and Colorectal Cancer Product
Table 132. Epigenomics Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 133. Epigenomics Recent Developments
Table 134. Exact Sciences Company Details
Table 135. Exact Sciences Business Overview
Table 136. Exact Sciences Anal and Colorectal Cancer Product
Table 137. Exact Sciences Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 138. Exact Sciences Recent Developments
Table 139. Genomictree Company Details
Table 140. Genomictree Business Overview
Table 141. Genomictree Anal and Colorectal Cancer Product
Table 142. Genomictree Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 143. Genomictree Recent Developments
Table 144. Immunovaccine Company Details
Table 145. Immunovaccine Business Overview
Table 146. Immunovaccine Anal and Colorectal Cancer Product
Table 147. Immunovaccine Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 148. Immunovaccine Recent Developments
Table 149. ISA Pharmaceuticals Company Details
Table 150. ISA Pharmaceuticals Business Overview
Table 151. ISA Pharmaceuticals Anal and Colorectal Cancer Product
Table 152. ISA Pharmaceuticals Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 153. ISA Pharmaceuticals Recent Developments
Table 154. Merck Company Details
Table 155. Merck Business Overview
Table 156. Merck Anal and Colorectal Cancer Product
Table 157. Merck Revenue in Anal and Colorectal Cancer Business (2017-2022) & (US$ Million)
Table 158. Merck Recent Developments
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anal and Colorectal Cancer Market Share by Type: 2021 VS 2028
Figure 2. Surgery Features
Figure 3. Radiation therapy Features
Figure 4. Colorectal cancer chemotherapy Features
Figure 5. Targeted therapy Features
Figure 6. Immunotherapy Features
Figure 7. Global Anal and Colorectal Cancer Market Share by Application: 2021 VS 2028
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory surgery centers Case Studies
Figure 10. Cancer research centers Case Studies
Figure 11. Anal and Colorectal Cancer Report Years Considered
Figure 12. Global Anal and Colorectal Cancer Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Anal and Colorectal Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Anal and Colorectal Cancer Market Share by Region: 2021 VS 2028
Figure 15. Global Anal and Colorectal Cancer Market Share by Players in 2021
Figure 16. Global Top Anal and Colorectal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anal and Colorectal Cancer as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Anal and Colorectal Cancer Revenue in 2021
Figure 18. North America Anal and Colorectal Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Anal and Colorectal Cancer Market Size Market Share by Type (2017-2028)
Figure 20. North America Anal and Colorectal Cancer Market Size Market Share by Application (2017-2028)
Figure 21. North America Anal and Colorectal Cancer Market Size Share by Country (2017-2028)
Figure 22. United States Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Anal and Colorectal Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Anal and Colorectal Cancer Market Size Market Share by Type (2017-2028)
Figure 26. Europe Anal and Colorectal Cancer Market Size Market Share by Application (2017-2028)
Figure 27. Europe Anal and Colorectal Cancer Market Size Share by Country (2017-2028)
Figure 28. Germany Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Anal and Colorectal Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Anal and Colorectal Cancer Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Anal and Colorectal Cancer Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Anal and Colorectal Cancer Market Size Share by Region (2017-2028)
Figure 38. China Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Anal and Colorectal Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Anal and Colorectal Cancer Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Anal and Colorectal Cancer Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Anal and Colorectal Cancer Market Size Share by Country (2017-2028)
Figure 48. Mexico Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Anal and Colorectal Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Anal and Colorectal Cancer Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Anal and Colorectal Cancer Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Anal and Colorectal Cancer Market Size Share by Country (2017-2028)
Figure 54. Turkey Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Anal and Colorectal Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Abbott Diagnostics Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 58. Advaxis Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 59. Abbott Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 60. Amgen Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 61. Atara Biotherapeutics Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 62. Bayer Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 63. Metabiomics Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 64. Beckman Coulter Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 65. BeiGene Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 66. Boehringer Ingelheim Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 67. Clinical Genomics Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 68. EDP Biotech Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 69. Eli Lilly Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 70. Epigenomics Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 71. Exact Sciences Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 72. Genomictree Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 73. Immunovaccine Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 74. ISA Pharmaceuticals Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 75. Merck Revenue Growth Rate in Anal and Colorectal Cancer Business (2017-2022)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount